HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abass Alavi Selected Research

Diaschisis

5/2019Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer's disease and mild cognitive impairment.
1/2017Prognostic Implications of Total Hemispheric Glucose Metabolism Ratio in Cerebrocerebellar Diaschisis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abass Alavi Research Topics

Disease

80Neoplasms (Cancer)
07/2022 - 01/2002
35Inflammation (Inflammations)
08/2022 - 10/2002
25Infections
07/2022 - 10/2002
22Atherosclerosis
01/2022 - 01/2002
20Breast Neoplasms (Breast Cancer)
07/2022 - 03/2002
14Lymphoma (Lymphomas)
01/2018 - 01/2002
13Alzheimer Disease (Alzheimer's Disease)
07/2022 - 02/2012
13Neoplasm Metastasis (Metastasis)
04/2021 - 07/2002
10Thyroid Neoplasms (Thyroid Cancer)
10/2019 - 01/2002
9Calcinosis
12/2021 - 01/2020
7Multiple Myeloma
07/2022 - 07/2019
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2013
7Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 09/2011
7Osteomyelitis
03/2016 - 01/2002
6Atherosclerotic Plaque (Atheroma)
01/2020 - 01/2009
6Melanoma (Melanoma, Malignant)
01/2019 - 08/2004
6Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 02/2002
5Glioma (Gliomas)
07/2022 - 02/2011
5Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2022 - 07/2007
5Prostatic Neoplasms (Prostate Cancer)
04/2021 - 01/2018
5Lung Neoplasms (Lung Cancer)
01/2019 - 12/2004
5Sarcoidosis (Schaumann Disease)
01/2017 - 01/2002
5Hypoxia (Hypoxemia)
09/2016 - 11/2009
5Carcinoma (Carcinomatosis)
07/2016 - 07/2002
5Congenital Hyperinsulinism
02/2013 - 02/2007
5Brain Neoplasms (Brain Tumor)
09/2011 - 01/2005
5Acquired Immunodeficiency Syndrome (AIDS)
01/2009 - 01/2002
4Diabetic Foot
07/2022 - 06/2007
4Pulmonary Embolism
01/2022 - 10/2003
4Dementia (Dementias)
01/2022 - 07/2003
4Pneumonia (Pneumonitis)
01/2021 - 02/2014
4Body Weight (Weight, Body)
01/2021 - 07/2002
4Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 01/2005
4Colorectal Neoplasms (Colorectal Cancer)
09/2016 - 01/2002
4Hodgkin Disease (Hodgkin's Disease)
01/2013 - 08/2003
4Fever of Unknown Origin
01/2009 - 01/2002
3Squamous Cell Carcinoma of Head and Neck
07/2022 - 01/2018
3Venous Thrombosis (Deep-Vein Thrombosis)
01/2022 - 04/2004
3Radiation Pneumonitis
01/2021 - 02/2014
3Osteoporosis
10/2020 - 01/2016
3Hypertension (High Blood Pressure)
01/2020 - 01/2002
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 01/2002
3Insulin Resistance
01/2020 - 01/2018
3Vasculitis (Vasculitides)
01/2020 - 10/2004
3Obesity
05/2019 - 01/2002
3Cognitive Dysfunction
05/2019 - 07/2003
3Chronic Obstructive Pulmonary Disease (COPD)
01/2019 - 11/2007
3Vascular Calcification
11/2018 - 04/2014
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2017 - 03/2012
3Fever (Fevers)
05/2009 - 10/2002
3Lung Diseases (Lung Disease)
01/2008 - 10/2004
2Angina Pectoris
10/2022 - 10/2021
2Amyloid Plaque
07/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

70Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2022 - 07/2002
32Glucose (Dextrose)FDA LinkGeneric
07/2022 - 03/2002
26FluoridesIBA
01/2022 - 05/2011
20Fluorine-18IBA
01/2022 - 10/2002
16Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2007
10Amyloid (Amyloid Fibrils)IBA
07/2022 - 02/2012
9Biological ProductsIBA
01/2020 - 08/2004
8RadiopharmaceuticalsIBA
07/2022 - 11/2004
7Indicators and Reagents (Reagents)IBA
12/2021 - 03/2002
6Sodium Fluoride (Ossin)FDA Link
10/2022 - 09/2018
6Pharmaceutical PreparationsIBA
07/2022 - 07/2007
6CalciumIBA
10/2020 - 05/2012
6ThyroglobulinFDA Link
10/2012 - 01/2002
5Monoclonal AntibodiesIBA
11/2013 - 05/2002
4Amino AcidsFDA Link
07/2022 - 01/2005
4Estrogens (Estrogen)FDA Link
04/2019 - 08/2006
4Radioisotopes (Radionuclides)IBA
07/2016 - 03/2002
4Colloids (Colloid)IBA
07/2014 - 09/2006
3Polyvinyl Chloride (PVC)IBA
07/2022 - 10/2011
3AntigensIBA
04/2021 - 12/2006
3SodiumIBA
01/2021 - 04/2014
3Protons (Proton)IBA
12/2020 - 01/2019
3CytokinesIBA
01/2020 - 08/2003
3CholesterolIBA
01/2020 - 01/2002
3Lipoproteins (Lipoprotein)IBA
01/2020 - 01/2012
3Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA
10/2019 - 09/2016
3Complement System Proteins (Complement)IBA
10/2015 - 01/2006
3AntibodiesIBA
10/2014 - 08/2005
3SulfurIBA
07/2014 - 09/2006
3Calcitonin (Calcitonin, Eel)FDA LinkGeneric
10/2012 - 07/2007
3Neurotransmitter Agents (Neurotransmitter)IBA
06/2011 - 04/2010
3Coloring Agents (Dyes)IBA
12/2010 - 03/2002
3IodineIBA
05/2009 - 03/2004
3Immunoglobulin G (IgG)IBA
03/2009 - 05/2002
3Dihydroxyphenylalanine (Dopa)IBA
10/2008 - 02/2007
3Progesterone Receptors (Progesterone Receptor)IBA
03/2008 - 08/2006

Therapy/Procedure

47Therapeutics
01/2022 - 01/2002
20Radiotherapy
01/2021 - 11/2004
14Drug Therapy (Chemotherapy)
01/2022 - 07/2002
13Prostheses and Implants (Prosthesis)
01/2020 - 01/2002
6Arthroplasty
07/2022 - 10/2002
6Radioimmunotherapy
01/2018 - 05/2002
4Aftercare (After-Treatment)
07/2016 - 01/2002
3Precision Medicine
02/2022 - 01/2013
3Intravenous Injections
01/2021 - 07/2002
3Chemoradiotherapy
06/2019 - 04/2015
3Neoadjuvant Therapy
11/2013 - 02/2009